Frazier Life Sciences Management, L.P. Zai Lab LTD Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Zai Lab LTD stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 350,000 shares of ZLAB stock, worth $14.2 Million. This represents 0.8% of its overall portfolio holdings.
Number of Shares
350,000Holding current value
$14.2 Million% of portfolio
0.8%Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
175Shares Held
52.2MCall Options Held
92.9KPut Options Held
318K-
Capital World Investors Los Angeles, CA6.01MShares$244 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$155 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.65MShares$148 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.28MShares$133 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY3.14MShares$127 Million1.86% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.98B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...